EMJ Urology 12.1 2024

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback

The worldwide prevalence of benign prostatic hyperplasia (BPH) varies between 20–60% in men over 50 years. Similarly, about 50% of men… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback

Erection is a neurovascular response accompanied by the release of neurotransmitters. The penis is innervated by autonomic (sympathetic… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback

Bladder cancers are classified into muscle-invasive and non-muscle-invasive, the latter accounting for 75% of cases.1 Accurate and timely… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback